Welcome to our dedicated page for Phreesia SEC filings (Ticker: PHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Phreesia filings document the company’s operating results, material agreements, capital structure and governance as a public healthcare technology company. Recent Form 8-K disclosures include quarterly financial results, stakeholder letters and earnings-call materials, along with material definitive agreements connected to credit facilities, acquisition financing and receivables arrangements.
The filing record also documents the completed AccessOne acquisition, the use and refinancing of related debt, and subsidiary arrangements involving AccessOne Funding and AccessOne MedCard. Governance disclosures include board composition changes, director compensation matters and shareholder-voting subjects, while capital-structure disclosures cover secured revolving credit, bridge-loan obligations and receivables purchase agreements.
Yvonne Hui, Principal Accounting Officer of Phreesia, Inc. (PHR) reported the sale of 940 shares of Phreesia common stock on 09/16/2025. The disposition occurred under a mandatory sell-to-cover program to satisfy tax withholding tied to the settlement of a restricted stock unit award. The weighted-average sale price reported was $23.2844 per share, with individual sale prices ranging from $22.83 to $23.69 per share. After the reported disposition, the filing shows 30,638 shares beneficially owned by the reporting person. The Form 4 was signed by Allison Hoffman as attorney-in-fact for Yvonne Hui on 09/18/2025.
Phreesia, Inc. insider Chaim Indig completed a small, routine sale of company stock to satisfy tax withholding after restricted stock units vested. The filing reports a disposition of 6,328 shares on 09/16/2025 at a weighted average price of $23.2844 per share, with sale prices ranging from $22.83 to $23.69. After the sale the reporting person beneficially owns 1,255,771 shares directly and 255,000 shares indirectly through the Indig Dynasty Trust.
The Form 4 notes the sale was non-discretionary under the issuer's mandatory sell-to-cover policy and that the indirect holdings are held in a family trust for immediate-family beneficiaries.
Phreesia, Inc. insider David Linetsky reported sales of Common Stock to satisfy tax withholding on vested restricted stock units and under a trading plan. On 09/16/2025 he disposed of 2,165 shares in two non-discretionary sell-to-cover transactions at a weighted average price of $23.2844 per share, and on 09/17/2025 he disposed of 1,064 shares at $23.50 per share pursuant to a Rule 10b5-1 plan adopted 01/15/2025. After these transactions he beneficially owned 173,888 shares directly and 9,976 shares indirectly (by spouse). The Form 4 was signed by power of attorney on 09/18/2025.
Evan Roberts, President, Provider Solutions at Phreesia, Inc. (PHR), reported a sale of 3,761 shares of common stock on 09/16/2025 at a weighted-average price of $23.2844 per share. After the transaction, the reporting person beneficially owned 726,837 shares. The filing states the shares were disposed of in non-discretionary transactions under the issuer's mandatory sell-to-cover policy to satisfy tax withholding obligations related to the settlement of restricted stock units. The sale was signed via power of attorney on 09/18/2025.
Phreesia insider sale by SVP, Human Resources. Amy Beth VanDuyn sold 1,762 shares of Phreesia, Inc. (PHR) on 09/16/2025 at a weighted average price of $23.2844 per share. The filing shows 112,479 shares beneficially owned by the reporting person after the transaction, held directly. The sale was disclosed as a non-discretionary, mandatory sell-to-cover to satisfy tax withholding obligations related to the settlement of restricted stock units; proceeds were realized across multiple transactions at prices ranging from $22.83 to $23.69 per share. The Form 4 was signed by Power of Attorney on 09/18/2025.
Phreesia, Inc. (PHR) filed a Form 144 reporting a proposed sale of 93 common shares through Fidelity Brokerage Services with an aggregate market value of $2,226.29, slated for 09/18/2025. The filing shows those 93 shares were acquired by restricted stock vesting on 09/15/2025 (35 shares) and 09/16/2025 (58 shares) and were received as compensation. The issuer has 59,914,473 shares outstanding, so the proposed sale represents a de minimis fraction of the outstanding stock. The filing also lists multiple insider sales over the past three months, including larger transactions by David Linetsky (e.g., 23,729 shares on 06/27/2025 for $676,195.48). The notice includes the standard signer representations about absence of undisclosed material information.
Phreesia, Inc. submitted a Form 144 notice disclosing a proposed sale of 1,064 common shares through Fidelity Brokerage Services on 09/17/2025 with an aggregate market value of $25,004.00. The filing reports 59,914,473 shares outstanding. The 1,064 shares were acquired on 09/11/2025 under a restricted stock vesting arrangement and paid as compensation. The filing also lists multiple sales by Jessica Weiss and David Linetsky during the prior three months, including larger blocks by Mr. Linetsky (e.g., 23,729 shares for $676,195.48 on 06/27/2025). The notice includes the standard attestation that the seller does not possess undisclosed material adverse information.
Form 144 filed for Phreesia, Inc. (PHR) shows a proposed sale of 2,059 common shares through Fidelity Brokerage Services with an aggregate market value of $48,386.50 and an approximate sale date of 09/17/2025. The shares were acquired by restricted stock vesting on 09/11/2025 and were issued as compensation. The filing reports total outstanding shares of 59,914,473. The filer also disclosed sales by Alison C. Hoffman within the past three months: 1,245 shares on 07/17/2025 for $33,472.82 and 3,133 shares on 09/16/2025 for $72,950.03. The notice includes the standard attestation that the seller is unaware of undisclosed material adverse information.
Phreesia, Inc. (PHR) filing reports a proposed sale of 940 common shares through Fidelity Brokerage Services with an aggregate market value of $21,887.34 and approximately 59,914,473 shares outstanding. The securities were acquired on 09/11/2025 through restricted stock vesting and the stated nature of payment is compensation. The filer lists an approximate sale date of 09/16/2025 on the NYSE. The filing also discloses recent open-market sales by the same person totaling 2,391 shares for $65,139.96 across trades dated 07/07/2025–07/18/2025. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
Phreesia, Inc. (PHR) filed a Form 144 reporting an intended sale of 1,762 common shares with an aggregate market value of $41,027.11, expected to occur on 09/16/2025 on the NYSE. The shares were acquired on 09/11/2025 through restricted stock vesting and were received as compensation.
The filer, identified as Amy Vanduyn, previously sold 640 shares on 07/17/2025 for $17,206.91 and 18,573 shares on 08/25/2025 for $564,055.11. The filing discloses there are 59,914,473 shares outstanding. The document includes the broker name and address (Fidelity Brokerage Services LLC) and a standard attestation that the seller is not aware of undisclosed material adverse information.